Trial Profile
Randomized, Double-blinded, Placebo-controlled, Multiple Oral Administration of ASP7991 to Non-elderly Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs ASP 7991 (Primary)
- Indications Secondary hyperparathyroidism
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 14 Apr 2014 New trial record